Drug Research
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services
Samsung Biologics , a leading global CDMO providing end-to-end contract development and manufacturing services, announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier...
News
SIRIO’s Nutra-Innovation Team tackles global surge in demand for novel mood and stress health formulations
SIRIO Group’s global Nutra-Innovation Team is rapidly intensifying efforts to create new formulations in different delivery formats for mood and stress relief. The team’s focus follows a year of global lockdowns in which consumers faced significant challenges. This has...
News
Oliver Healthcare Packaging Wins Packaging Design of the Year at Healthcare Asia Medtech Awards 2021
Oliver Healthcare Packaging, a leading healthcare company that drives innovation in medical packaging, has been recognised as the winner in the Packaging Design of the Year category at Charlton Media Group’s Healthcare Asia Medtech Awards 2021. This award is...
News
PeliBioThermalAdds Service Offerings for Single-Use Products
PeliBioThermal, the global name in temperature controlled packaging solutions, announces new service offerings that support customers who use single use products, such as CoolPall™ Flex single use bulk shippers and CoolGuard™ Advance single use parcel shippers. The company now...
News
Vetter Once Again Wins Axia Best Managed Companies Award
For the second time in a row, Vetter, a global leading contract development and manufacturing organization (CDMO), has won the Axia Best Managed Companies Award. The pharmaceutical service provider was again honored for its clear vision, innovative approaches, sustainable...
Clinical Trials
Moderna Reports Positive COVID-19 Vaccine Results in Adolescents
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination....
News
CanSino Biologics Gets OGYEI GMP Certificate for COVID Vax
CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI). The certification was issued on May 21, 2021...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read